Cargando…

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome

After shifting away from invasive mechanical ventilation and intratracheal instillation of surfactant toward non-invasive ventilation with nasal CPAP and less invasive surfactant administration in order to prevent bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome, full...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walther, Frans J., Waring, Alan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240419/ https://www.ncbi.nlm.nih.gov/pubmed/35783301 http://dx.doi.org/10.3389/fped.2022.923010

Ejemplares similares

Aerosol delivery of synthetic lung surfactant
por: Walther, Frans J., et al.
Publicado: (2014)

Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome
por: Walther, Frans J., et al.
Publicado: (2021)

Aerosol delivery of dry powder synthetic lung surfactant to surfactant-deficient rabbits and preterm lambs on non-invasive respiratory support
por: Walther, Frans J., et al.
Publicado: (2019)

Efficacy, dose–response, and aerosol delivery of dry powder synthetic lung surfactant treatment in surfactant-deficient rabbits and premature lambs
por: Walther, Frans J., et al.
Publicado: (2022)

Effect of Nasal Continuous Airway Pressure With and Without Surfactant Administration for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
por: Malibary, Husam, et al.
Publicado: (2023)

A Fixed Flow is More Effective than Titrated Flow during Bubble Nasal CPAP for Respiratory Distress in Preterm Neonates
por: Murki, Srinivas, et al.
Publicado: (2015)

Evaluation of a Novel Dry Powder Surfactant Aerosol Delivery System for Use in Premature Infants Supported with Bubble CPAP
por: DiBlasi, Robert M., et al.
Publicado: (2023)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
por: Mikolajcikova, Silvia, et al.
Publicado: (2022)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
por: Han, Tongyan, et al.
Publicado: (2020)

FiO(2) Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
por: Kruczek, Piotr, et al.
Publicado: (2021)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Design of Surfactant Protein B Peptide Mimics Based on the Saposin Fold for Synthetic Lung Surfactants
por: Walther, Frans J., et al.
Publicado: (2016)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
por: Duan, Xudong, et al.
Publicado: (2022)

CPAP failure in the management of preterm neonates with respiratory distress syndrome where surfactant is scarce. A prospective observational study
por: Abdallah, Yaser, et al.
Publicado: (2023)

Lung Ultrasound for the Diagnosis and Management of Neonatal Respiratory Distress Syndrome: A Minireview
por: Guo, Bin-Bin, et al.
Publicado: (2022)

Lung ultrasound to guide the administration of exogenous pulmonary surfactant in respiratory distress syndrome of newborn infants: A retrospective investigation study
por: Liu, Jing, et al.
Publicado: (2022)

Neonatal Joubert Syndrome With Renal Involvement and Respiratory Distress
por: Agarwal, Beena D, et al.
Publicado: (2022)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
por: Yalaz, Mehmet, et al.
Publicado: (2022)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
por: Greiner, Eva, et al.
Publicado: (2021)

Emulation of the structure of the Saposin protein fold by a lung surfactant peptide construct of surfactant Protein B
por: Waring, Alan J., et al.
Publicado: (2022)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
por: Amatya, Shaili, et al.
Publicado: (2021)

Maternal-Neonatal Serum Albumin Level and Neonatal Respiratory Distress Syndrome in Late-Preterm Infants
por: Ying, Qian, et al.
Publicado: (2021)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
por: Amatya, Shaili, et al.
Publicado: (2022)

Prospective Evaluation of the Correlation of Lung Ultrasonography Score and Blood Gas Parameters in Neonates With Respiratory Distress
por: Tandircioglu, Umit Ayse, et al.
Publicado: (2023)

Accuracy of Spontaneous Breathing Trial Using ET-CPAP in Predicting Successful Extubation of Neonates
por: Khan, Azeem, et al.
Publicado: (2021)

Lung Surfactant Protein B Peptide Mimics Interact with the Human ACE2 Receptor
por: Waring, Alan J., et al.
Publicado: (2023)

Structural and functional stability of the sulfur-free surfactant protein B peptide mimic B-YL in synthetic surfactant lipids
por: Walther, Frans J., et al.
Publicado: (2021)

Roles of Lung Ultrasound Score in the Extubation Failure From Mechanical Ventilation Among Premature Infants With Neonatal Respiratory Distress Syndrome
por: Liang, Zhenyu, et al.
Publicado: (2021)

Bubble–CPAP vs. Ventilatory–CPAP in Preterm Infants with Respiratory Distress
por: Bahman-Bijari, Bahareh, et al.
Publicado: (2011)

Decoding the neonatal chest radiograph: An insight into neonatal respiratory distress
por: Jain, Sanjay N, et al.
Publicado: (2020)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Clinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome
por: Zhang, Congmin, et al.
Publicado: (2017)

Plasma Cytokine Levels Fall in Preterm Newborn Infants on Nasal CPAP with Early Respiratory Distress
por: Carvalho, Clarissa Gutierrez, et al.
Publicado: (2015)

A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol
por: Zhang, Hui, et al.
Publicado: (2022)

Impact of hypothermia on implementation of CPAP for neonatal respiratory distress syndrome in a low-resource setting
por: Carns, Jennifer, et al.
Publicado: (2018)

Evaluation of the neonatal sequential organ failure assessment and mortality risk in neonates with respiratory distress syndrome: A retrospective cohort study
por: Shi, Shanshan, et al.
Publicado: (2022)

Editorial: Respiratory distress syndrome
por: Erdeve, Ömer, et al.
Publicado: (2022)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Venoarterial Extracorporeal Membrane Oxygenation for Severe Neonatal Acute Respiratory Distress Syndrome in a Developing Country
por: Hong, Xiaoyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_116rhqunnpasndg7kug9jc4598